U-albumin 6(treatment)+3(follow-up) months [clinicaltrials_resource:f716e77ae913f217a1c27d2c95599659]
The patient is his own control. Endpoint variables are measured before, during and after treatment.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
U-albumin 6(treatment)+3(follow-up) months [clinicaltrials_resource:f716e77ae913f217a1c27d2c95599659]
The patient is his own control. Endpoint variables are measured before, during and after treatment.
Bio2RDF identifier
f716e77ae913f217a1c27d2c95599659
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f716e77ae913f217a1c27d2c95599659
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
6(treatment)+3(follow-up) months
description
The patient is his own control ...... e, during and after treatment.
identifier
clinicaltrials_resource:f716e77ae913f217a1c27d2c95599659
title
U-albumin 6(treatment)+3(follow-up) months
@en
type
label
U-albumin 6(treatment)+3(follo ...... 6e77ae913f217a1c27d2c95599659]
@en